SNORD66 and chronic obstructive pulmonary disease: However, when plasma expression of SNORD66 was compared between NSCLC and COPD groups, it was significantly higher in the NSCLC patients as compared with the COPD patients (P < 0.01) (Table 3, Fig. 2).